Strategic Wealth Partners, Ltd. Novartis Ag Transaction History

Strategic Wealth Partners, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$80.93 - $91.1 $1.05 Million - $1.18 Million	-12,999 Closed	0 $0
Q4 2019 Jan 30, 2020	SELL	$84.35 - $95.37 $4,976 - $5,626	-59 Reduced 0.45%	12,999 $1.23 Million
Q3 2019 Oct 28, 2019	BUY	$85.54 - $94.26 $800,312 - $881,896	9,356 Added 252.73%	13,058 $86 Million
Q2 2019 Aug 06, 2019	SELL	$75.4 - $92.8 $58,058 - $71,456	-770 Reduced 17.22%	3,702 $337,000
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $42,781 - $48,933	568 Added 14.55%	4,472 $429,000
Q4 2018 Jan 24, 2019	SELL	$73.66 - $82.02 $10,312 - $11,482	-140 Reduced 3.46%	3,904 $300,000
Q3 2018 Dec 06, 2018	SELL	$66.94 - $77.43 $36,549 - $42,276	-546 Reduced 11.9%	4,044 $348,000
Q2 2018 Sep 04, 2018	SELL	$64.91 - $73.36 $145,268 - $164,179	-2,238 Reduced 32.78%	4,590 $347,000
Q1 2018 Jul 13, 2018	BUY	$70.39 - $84.15 $480,622 - $574,576	6,828 New	6,828 $552,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.